Cancer Innovation
FDA Grants Accelerated Approval to Camizestrant for Adults
The agency approved the estrogen receptor antagonist for use in combination with a CDK4/6 inhibitor.
Emerging2 min read
Section
Cancer Innovation
Reporting on how cancer care is changing: new therapeutic classes, resistance biology, combination strategies, and the practical distance between a promising result and a treatment a patient can actually receive.
Evidence stage
Cancer Innovation
FDA Grants Accelerated Approval to Sevabertinib for Non-Squamous NSCLC
The agency approved the kinase inhibitor for adult patients with locally advanced or metastatic disease.
Emerging1 min read
Cancer Innovation
FAPI Radionuclide Theranostics Show Promise in Sarcoma Diagnosis and Treatment
A systematic review indicates FAPI PET outperforms standard imaging for detecting sarcoma lesions while FAPI radionuclide therapy demonstrates clinical activity.
Established3 min read
Cancer Innovation
Study Explores How Oxygen Levels Reshape Tumor Signaling in Liver Cancer
Research indicates the lncRNA MIR100HG behaves differently depending on cellular oxygen levels, acting as a context-dependent regulator in liver cancer cells.
Emerging2 min read
Cancer Innovation
Why Some Colorectal Cancers Resist Immunotherapy and How Science Aims to Fight Back
Researchers trace the genetic and environmental barriers to immunotherapy in mismatch repair-deficient colorectal cancers.
Emerging2 min read
Cancer Innovation
Quarter-Century Bibliometric Analysis Charts Major Shifts in Solid Tumor Immunotherapy Research
A study tracking 25 years of publication data maps how the clinical and academic focus has transitioned toward neoadjuvant and combination strategies.
Established2 min read
Cancer Innovation
Plant-Derived Compound Dicentrine Suppresses Lymphoma Cells in Preclinical Study
An alkaloid isolated from Stephania venosa halts cancer cell proliferation and triggers programmed cell death in vitro.
Emerging3 min read
Cancer Innovation
Researchers Identify Gene Linking Specific Immune Cells to Gastric Cancer Progression
A study using spatial transcriptomics and machine learning highlights the role of SERPINE1 in tumor stromal remodeling.
Emerging3 min read
Cancer Innovation
Engineering Circular RNA for Sustained Expression in Precision Oncology
By joining the ends of the RNA strand into a loop, researchers are evaluating circular RNA to resist degradation and extend protein expression in cancer applications.
Emerging2 min read
Cancer Innovation
A New Nanoparticle Design Seeks to Heat Up and Activate Stubborn Cancer Tumors
Researchers have designed a biodegradable nanoparticle that combines chemotherapy, heat, and immunotherapy to target resistant solid tumors.
Emerging2 min read